499 related articles for article (PubMed ID: 20947221)
21. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
22. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of 6-cinnamoyl-2H-benzo[b][1,4]oxazin-3(4H)-ones and their effects on A549 lung cancer cell growth.
Zhou XW; Ma HL; Zhang X; Jing SY; Miao JY; Zhao BX
Eur J Med Chem; 2014 May; 79():95-101. PubMed ID: 24727462
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of di-phenyl-tin(IV)-salicyliden-ortho-aminophenols: analysis of in vitro antitumor/antioxidant activities and molecular structures.
Beltrán HI; Damian-Zea C; Hernández-Ortega S; Nieto-Camacho A; Ramírez-Apan MT
J Inorg Biochem; 2007 Jul; 101(7):1070-85. PubMed ID: 17555822
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity.
Havrylyuk D; Zimenkovsky B; Vasylenko O; Zaprutko L; Gzella A; Lesyk R
Eur J Med Chem; 2009 Apr; 44(4):1396-404. PubMed ID: 19000643
[TBL] [Abstract][Full Text] [Related]
28. New synthesis of two tridentate bipyrazolic compounds and their cytotoxic activity tumor cell lines.
El Kodadi M; Benamar M; Ibrahim B; Zyad A; Malek F; Touzani R; Ramdani A; Melhaoui A
Nat Prod Res; 2007 Sep; 21(11):947-52. PubMed ID: 17691042
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, X-ray crystal structure and fluorescent spectra of novel pyrazolo[1,5-a]pyrazin-4(5H)-one derivatives.
Zheng LW; Gong ZL; Liu WL; Liu YR; Zhao BX
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Oct; 81(1):372-9. PubMed ID: 21733750
[TBL] [Abstract][Full Text] [Related]
31. Efficient microwave-assisted synthesis and antitumor activity of novel 4,4'-methylenebis[2-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)phenols].
Insuasty B; García A; Quiroga J; Abonia R; Ortiz A; Nogueras M; Cobo J
Eur J Med Chem; 2011 Jun; 46(6):2436-40. PubMed ID: 21481989
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity.
Li X; Liu JL; Yang XH; Lu X; Zhao TT; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Jul; 20(14):4430-6. PubMed ID: 22705022
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and bioactivities of novel pyrazole and triazole derivatives containing 5-phenyl-2-furan.
Cui ZN; Shi YX; Cui JR; Ling Y; Li BJ; Yang XL
Chem Biol Drug Des; 2012 Jan; 79(1):121-7. PubMed ID: 22023821
[TBL] [Abstract][Full Text] [Related]
35. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents.
Rostom SA
Bioorg Med Chem; 2010 Apr; 18(7):2767-76. PubMed ID: 20207545
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of 3beta, 7alpha, 11alpha-trihydroxy-pregn-21-benzylidene-5-en-20-one derivatives and their cytotoxic activities.
Shan LH; Liu HM; Huang KX; Dai GF; Cao C; Dong RJ
Bioorg Med Chem Lett; 2009 Dec; 19(23):6637-9. PubMed ID: 19864129
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomas.
Comes Franchini M; Bonini BF; Camaggi CM; Gentili D; Pession A; Rani M; Strocchi E
Eur J Med Chem; 2010 May; 45(5):2024-33. PubMed ID: 20129719
[TBL] [Abstract][Full Text] [Related]
38. [Synthesis of 1-furfuryl-indolin-2-one derivatives and preliminary evaluation of their antitumor activities].
Dong XC; Zhou FS; Zheng JB; Wen R
Yao Xue Xue Bao; 2008 Jan; 43(1):54-9. PubMed ID: 18357732
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles.
Saczewski F; Reszka P; Gdaniec M; Grünert R; Bednarski PJ
J Med Chem; 2004 Jun; 47(13):3438-49. PubMed ID: 15189040
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
